Conformis Inc. [NASDAQ: CFMS] stock went on an upward path that rose over 12.26% on Tuesday, amounting to a one-week price increase of more than 10.19%. The company report on March 2, 2021 that Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System.
The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient’s knee, and provide optimal stability throughout the full range of motion.
Conformis, Inc. (NASDAQ: CFMS) announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic Goods Administration, which is part of the Australian Department of Health, and which authorizes the marketing of medical devices and other healthcare products in Australia.
Over the last 12 months, CFMS stock rose by 33.42%. The average equity rating for CFMS stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $216.32 million, with 176.50 million shares outstanding and 77.72 million shares in the current float. Compared to the average trading volume of 5.15M shares, CFMS stock reached a trading volume of 44434371 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Conformis Inc. [CFMS]:
BTIG Research have made an estimate for Conformis Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 01, 2019. The new note on the price target was released on January 02, 2018, representing the official price target for Conformis Inc. stock. On August 04, 2017, analysts decreased their price target for CFMS shares from 6 to 5.
The Average True Range (ATR) for Conformis Inc. is set at 0.16, with the Price to Sales ratio for CFMS stock in the period of the last 12 months amounting to 3.00. The Price to Book ratio for the last quarter was 4.58.
CFMS Stock Performance Analysis:
Conformis Inc. [CFMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.19. With this latest performance, CFMS shares gained by 14.42% in over the last four-week period, additionally plugging by 75.00% over the last 6 months – not to mention a rise of 33.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CFMS stock in for the last two-week period is set at 53.77, with the RSI for the last a single of trading hit 54.77, and the three-weeks RSI is set at 54.15 for Conformis Inc. [CFMS]. The present Moving Average for the last 50 days of trading for this stock 1.0223, while it was recorded at 1.0800 for the last single week of trading, and 0.8319 for the last 200 days.
Insight into Conformis Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Conformis Inc. [CFMS] shares currently have an operating margin of -32.37 and a Gross Margin at +47.45. Conformis Inc.’s Net Margin is presently recorded at -36.78.
Return on Total Capital for CFMS is now -53.60, given the latest momentum, and Return on Invested Capital for the company is -61.89. Return on Equity for this stock declined to -108.39, with Return on Assets sitting at -41.82. When it comes to the capital structure of this company, Conformis Inc. [CFMS] has a Total Debt to Total Equity ratio set at 160.05. Additionally, CFMS Total Debt to Total Capital is recorded at 61.55, with Total Debt to Total Assets ending up at 36.14. Long-Term Debt to Equity for the company is recorded at 151.06, with the Long-Term Debt to Total Capital now at 58.09.
Reflecting on the efficiency of the workforce at the company, Conformis Inc. [CFMS] managed to generate an average of -$105,085 per employee. Receivables Turnover for the company is 6.29 with a Total Asset Turnover recorded at a value of 1.14.Conformis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.90.
CFMS Stock EPS
With the latest financial reports released by the company, Conformis Inc. posted -0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.1/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 20.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CFMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Conformis Inc. go to -14.58%.
Conformis Inc. [CFMS] Insider Position Details
There are presently around $20 million, or 16.30% of CFMS stock, in the hands of institutional investors. The top three institutional holders of CFMS stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 5,882,971, which is approximately 12.828% of the company’s market cap and around 1.40% of the total institutional ownership; ARCHON CAPITAL MANAGEMENT LLC, holding 3,859,863 shares of the stock with an approximate value of $4.09 million in CFMS stocks shares; and VANGUARD GROUP INC, currently with $3.36 million in CFMS stock with ownership of nearly 3.845% of the company’s market capitalization.
Positions in Conformis Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 18 institutional holders increased their position in Conformis Inc. [NASDAQ:CFMS] by around 1,522,761 shares. Additionally, 20 investors decreased positions by around 8,638,106 shares, while 24 investors held positions by with 8,953,786 shares. The mentioned changes placed institutional holdings at 19,114,653 shares, according to the latest SEC report filing. CFMS stock had 5 new institutional investments in for a total of 289,130 shares, while 9 institutional investors sold positions of 7,763,299 shares during the same period.